Literature DB >> 7914091

Evidence supporting catalytic roles for aspartate residues in phosphoribulokinase.

H A Charlier1, J A Runquist, H M Miziorko.   

Abstract

The DNA encoding Rhodobacter sphaeroides phosphoribulokinase (PRK) has been modified to allow ligation into pET-3d. Using the resulting expression plasmid, PRK was overexpressed in Escherichia coli and isolated in milligram quantities. Homogeneous preparations of the enzyme exhibit properties comparable to those of PRK expressed using a previously described pUC19-derived construct [Sandbaken et al., Biochemistry 31, 3715-3719]. Mutagenesis experiments have been designed to produce conservative substitutions that eliminate the carboxyl groups of each of four conserved acidic residues (D42, E131, D169, and E178). Using the newly developed expression system, the resulting PRK variants have been expressed, isolated, and characterized. Expression levels and recoveries upon affinity chromatography purification are similar to the results obtained with wild-type PRK. Apparent substrate affinities of these mutant proteins do not differ greatly from values observed for wild-type PRK. In contrast, these PRK variants display a wide range of Vmax values, ranging from wild-type activity (approximately 200 units/mg; E178A) to levels that are diminished by 4 (D169A) to 5 (D42A, D42N) orders of magnitude. That the large diminutions in catalytic activity are significant and do not merely reflect gross perturbations in protein structure is suggested not only by the modest effects on substrate affinity but also by the allosteric properties of D169A, D42A, and D42N. The activities of these proteins, like that of wild-type PRK, are markedly stimulated by the positive effector NADH. The magnitude of the Vmax perturbations suggests that D42 and D169 are candidates for the role of active site base or activator cation ligand.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914091     DOI: 10.1021/bi00197a039

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Evolution of the genetic code by incorporation of amino acids that improved or changed protein function.

Authors:  Brian R Francis
Journal:  J Mol Evol       Date:  2013-06-07       Impact factor: 2.395

2.  Arabidopsis and Chlamydomonas phosphoribulokinase crystal structures complete the redox structural proteome of the Calvin-Benson cycle.

Authors:  Libero Gurrieri; Alessandra Del Giudice; Nicola Demitri; Giuseppe Falini; Nicolae Viorel Pavel; Mirko Zaffagnini; Maurizio Polentarutti; Pierre Crozet; Christophe H Marchand; Julien Henri; Paolo Trost; Stéphane D Lemaire; Francesca Sparla; Simona Fermani
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-28       Impact factor: 11.205

3.  Crystallization and preliminary X-ray crystallographic analysis of phosphoribulokinase from Rhodobacter sphaeroides.

Authors:  D L Roberts; J A Runquist; H M Miziorko; J J Kim
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

4.  Mechanistic characterization of the tetraacyldisaccharide-1-phosphate 4'-kinase LpxK involved in lipid A biosynthesis.

Authors:  Ryan P Emptage; Charles W Pemble; John D York; Christian R H Raetz; Pei Zhou
Journal:  Biochemistry       Date:  2013-03-19       Impact factor: 3.162

5.  Functional contribution of a conserved, mobile loop histidine of phosphoribulokinase.

Authors:  Jennifer A Runquist; Henry M Miziorko
Journal:  Protein Sci       Date:  2006-03-07       Impact factor: 6.725

6.  Physiological control and regulation of the Rhodobacter capsulatus cbb operons.

Authors:  G C Paoli; P Vichivanives; F R Tabita
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

7.  Potential use of sugar binding proteins in reactors for regeneration of CO2 fixation acceptor D-Ribulose-1,5-bisphosphate.

Authors:  Sourav Mahato; Debojyoti De; Debajyoti Dutta; Moloy Kundu; Sumana Bhattacharya; Marc T Schiavone; Sanjoy K Bhattacharya
Journal:  Microb Cell Fact       Date:  2004-06-02       Impact factor: 5.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.